BioSpace News Archive

Developing a Human Factors Validation Plan with Consideration for the Digital Health Marketplace

Polyphor AG shareholders approved all motions put forward by the Board of Directors to the 22nd Annual General Meeting in Basel.

The shareholders in Recipharm AB (publ), reg. no. 556498-8425, are hereby invited to attend the Annual General Meeting (“AGM”) to be held on Monday 13 May 2019 at 3.00 pm at IVA Konferenscenter, Grev Turegatan 16 in Stockholm, Sweden.

Radiology Services Inc. of Topsfield, Mass., has installed five CARESTREAM Q-Rad X-ray Systems at Lowell General Hospital.

Polyphor AG announced that the US Food and Drug Administration has designated murepavadin as a Qualified Infectious Disease Product in four additional indications; hospital-acquired bacterial pneumonia, acute bacterial skin and skin structure infection, bloodstream infection and complicated intra-abdominal infection.

The new accounting standard, IFRS 16 will have an estimated positive impact on EBITDA of SEK 90 million in 2019.

Researchers at LA BioMed in Torrance, CA have been working to create a therapeutic vaccine for 2 years to fight infections caused by Candida auris.

NOXXON Pharma N.V. announced its financial results for the fiscal year ending December 31, 2018.

PLENITY is FDA cleared for the largest number of adults struggling with overweight and obesity (BMI 25-40 kg/m2) of any prescription weight-management aid and the first that can be used, along with diet and exercise, in millions of overweight adults who have never before had prescription options

Quotes for attribution to National Kidney Foundation